DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 141 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,009,648 | +14.3% | 68,358 | 0.0% | 0.01% | +14.3% |
Q2 2023 | $883,185 | +44.7% | 68,358 | +9.8% | 0.01% | +40.0% |
Q1 2023 | $610,477 | -7.8% | 62,230 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $662,127 | +1.9% | 62,230 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $649,681 | -15.2% | 62,230 | +2.2% | 0.01% | 0.0% |
Q2 2022 | $766,429 | +22.9% | 60,876 | +5.8% | 0.01% | +50.0% |
Q1 2022 | $623,766 | +21.3% | 57,543 | +57.4% | 0.00% | 0.0% |
Q4 2021 | $514,385 | -26.8% | 36,559 | 0.0% | 0.00% | -42.9% |
Q3 2021 | $702,298 | +68.8% | 36,559 | -13.5% | 0.01% | +75.0% |
Q2 2021 | $416,123 | +0.2% | 42,246 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $415,278 | +98.3% | 42,246 | -10.2% | 0.00% | +100.0% |
Q4 2020 | $209,430 | +17.0% | 47,063 | +13.5% | 0.00% | 0.0% |
Q3 2020 | $179,073 | -51.3% | 41,452 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $367,679 | +151.3% | 41,452 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $146,326 | -38.3% | 41,452 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $237,105 | +60.0% | 41,452 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $148,191 | +29.5% | 41,452 | +44.5% | 0.00% | +100.0% |
Q2 2019 | $114,473 | -45.4% | 28,690 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $209,724 | -20.1% | 28,690 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $262,514 | -26.2% | 28,690 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $355,756 | -18.8% | 28,690 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $438,000 | -23.0% | 28,690 | 0.0% | 0.01% | -28.6% |
Q1 2018 | $569,000 | +6.0% | 28,690 | 0.0% | 0.01% | +16.7% |
Q4 2017 | $537,000 | – | 28,690 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |